[Plasma suPAR level in patients with multiple myeloma].

Zhongguo Shi Yan Xue Ye Xue Za Zhi

Department of Hematology, The Affiliated Hospital of Qingdao University Medical College, Qingdao 266003, Shandong Province, China.

Published: February 2008

To investigate the changes of plasma suPAR level in patients with multiple myeloma, ELISA was used to detect plasma suPAR level, and routine examination was performed for other clinical indexes in 26 multiple myeloma patients. The results showed that plasma suPAR level in patients was 4.31+/-1.67 ng/ml, which was obviously higher than that in control group (1.87+/-0.27 ng/ml) (p<0.01). Plasma suPAR level in IgM subtype patients was 6.18+/-3.61 ng/ml, which was highest among all the subtypes; the plasma suPAR levels in non-secretion subtype, IgG and IgA subtype were 4.43+/-1.55 ng/ml, 4.00+/-0.95 ng/ml and 3.50+/-1.60 ng/ml respectively. The plasma suPAR levels in all subtypes were higher than that in control group, but there was no differences between these subtypes. SuPAR level was correlated with the blood sedimentation rate, creatinine level and hemoglobin level, plasma cell ratio and M protein level. It is concluded that the change of plasma suPAR level in multiple myeloma contributes to predict the development and prognosis of the disease.

Download full-text PDF

Source

Publication Analysis

Top Keywords

supar level
16
level patients
12
plasma supar
12
patients multiple
8
multiple myeloma
8
[plasma supar
4
level
4
patients
4
multiple myeloma]
4
myeloma] investigate
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!